- Home
- POAI vs PRTG Comparison
POAI vs PRTG Comparison
Compare POAI & PRTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- PRTG
- Stock Information
- Founded
- POAI 2002
- PRTG 1973
- Country
- POAI United States
- PRTG British Virgin Islands
- Employees
- POAI N/A
- PRTG N/A
- Industry
- POAI Industrial Specialties
- PRTG Oil & Gas Production
- Sector
- POAI Health Care
- PRTG Energy
- Exchange
- POAI Nasdaq
- PRTG Nasdaq
- Market Cap
- POAI 4.9M
- PRTG 5.3M
- IPO Year
- POAI N/A
- PRTG N/A
- Fundamental
- Price
- POAI $0.69
- PRTG $4.09
- Analyst Decision
- POAI Hold
- PRTG Hold
- Analyst Count
- POAI 1
- PRTG 1
- Target Price
- POAI N/A
- PRTG N/A
- AVG Volume (30 Days)
- POAI 119.5K
- PRTG 51.9K
- Earning Date
- POAI 11-12-2024
- PRTG 11-26-2024
- Dividend Yield
- POAI N/A
- PRTG N/A
- EPS Growth
- POAI N/A
- PRTG N/A
- EPS
- POAI N/A
- PRTG N/A
- Revenue
- POAI $1,484,223.00
- PRTG N/A
- Revenue This Year
- POAI N/A
- PRTG N/A
- Revenue Next Year
- POAI $502.91
- PRTG N/A
- P/E Ratio
- POAI N/A
- PRTG N/A
- Revenue Growth
- POAI N/A
- PRTG N/A
- 52 Week Low
- POAI $0.55
- PRTG $2.10
- 52 Week High
- POAI $3.76
- PRTG $40.80
- Technical
- Relative Strength Index (RSI)
- POAI 44.88
- PRTG 35.81
- Support Level
- POAI $0.70
- PRTG $3.80
- Resistance Level
- POAI $0.89
- PRTG $4.49
- Average True Range (ATR)
- POAI 0.11
- PRTG 0.53
- MACD
- POAI 0.00
- PRTG -0.15
- Stochastic Oscillator
- POAI 14.64
- PRTG 12.12
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About PRTG Portage Biotech Inc.
Portage Biotech Inc is engaged in researching and developing pharmaceutical and biotech products through clinical proof of concept with an initial focus on unmet clinical needs. It is an immune-oncology company focused on overcoming immune resistance and currently managing 10 immuno-oncology assets at various development stages. Its pipeline products include IMM-60; IMM60 + Cell Therapy; (IMM60 / NY-ESO-1) + Keytruda and others.